Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Metra and Javed Butler.
Marco Metra
Connection Strength
1.611
Javed Butler
  1. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
    View in: PubMed
    Score: 0.223
  2. Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail. 2019 02; 21(2):163-171.
    View in: PubMed
    Score: 0.200
  3. A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials. J Card Fail. 2018 11; 24(11):783-792.
    View in: PubMed
    Score: 0.196
  4. Integrating electronic health records into the study of heart failure: promises and pitfalls. Eur J Heart Fail. 2017 09; 19(9):1128-1130.
    View in: PubMed
    Score: 0.179
  5. Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. Circ Heart Fail. 2017 Apr; 10(4).
    View in: PubMed
    Score: 0.178
  6. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev. 2014 Mar; 19(2):135-52.
    View in: PubMed
    Score: 0.143
  7. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020 12 12; 396(10266):1895-1904.
    View in: PubMed
    Score: 0.057
  8. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117.
    View in: PubMed
    Score: 0.055
  9. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e004783.
    View in: PubMed
    Score: 0.049
  10. A new educational program in heart failure drug development: the Brescia international master program. J Cardiovasc Med (Hagerstown). 2018 Aug; 19(8):411-421.
    View in: PubMed
    Score: 0.049
  11. Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. J Card Fail. 2018 Aug; 24(8):512-519.
    View in: PubMed
    Score: 0.049
  12. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC Heart Fail. 2018 04; 6(4):298-307.
    View in: PubMed
    Score: 0.047
  13. Redefining biomarkers in heart failure. Heart Fail Rev. 2018 03; 23(2):237-253.
    View in: PubMed
    Score: 0.047
  14. Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF. Clin Res Cardiol. 2018 Feb; 107(2):170-181.
    View in: PubMed
    Score: 0.046
  15. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Eur Heart J. 2017 Aug 07; 38(30):2364-2373.
    View in: PubMed
    Score: 0.045
  16. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.